Join the Actiq group to help and get support from people like you.
Actiq News (Page 3)
Most Injection Drug Users Are Not Seeking Out Fentanyl: Study
THURSDAY, June 1, 2023 – Many Americans who inject illicit drugs are unknowingly getting fentanyl mixed in with their heroin, which can increase their risk for overdose and perhaps their tolerance...
FDA Medwatch Alert: Teva Initiates Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Due to a Labeling Error
April 27, 2023, Parsippany, NJ – Teva Pharmaceuticals USA, has initiated a voluntary nationwide recall of specific lots of various strengths of Fentanyl Buccal Tablets CII to the Consumer Level....
FDA Medwatch Alert: Drug Safety Communication: All Opioid Pain Medicines - FDA Updates Prescribing Information to Provide Additional Guidance for Safe Use
ISSUE: The FDA is requiring several updates to the prescribing information for both immediate-release (IR) and extended release/long acting (ER/LA) opioid pain medicines. This includes stating for a...
FDA Medwatch Alert: FDA Alerts Health Care Professionals of Risks to Patients Exposed to Xylazine in Illicit Drugs
November 8, 2022 -- Health care professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to reverse its ...
FDA Medwatch Alert: FDA Alerts Health Care Professionals of Risks to Patients Exposed to Xylazine in Illicit Drugs
November 8, 2022 -- Health care professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to reverse its ...
FDA Medwatch Alert: Alvogen Inc. Issues Voluntary Nationwide Recall of Fentanyl Transdermal System Due to Product Mislabeling
April 19, 2019 – Alvogen, Inc. is voluntarily recalling two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches to the consumer level. A small number of cartons labeled 12 mcg/h...
FDA Medwatch Alert: Implanted Pumps: Safety Communication - Use Caution When Selecting Pain Medicine for Intrathecal Administration
ISSUE: The FDA is aware that patients undergoing treatment or management of pain are commonly given pain medicines in the spinal fluid (intrathecal administration) that are not FDA approved for use...
FDA Medwatch Alert: Injectable Products by SCA Pharmaceuticals: Recall - Potential Contamination
ISSUE: SCA Pharmaceuticals LLC (“SCA Pharmaceuticals”) is voluntarily recalling various lots of injectable products to the hospital level. There is a potential for the products to contain microbial co...
FDA Medwatch Alert: Opioid Pain or Cough Medicines Combined With Benzodiazepines: Drug Safety Communication - FDA Requiring New Boxed Warnings About Serious Risks and Death
ISSUE: FDA review has found that the growing combined use of opioid medicines with benzodiazepines or other drugs that depress the central nervous system (CNS) has resulted in serious side effects,...
FDA Medwatch Alert: Opioid Pain Medicines: Drug Safety Communication - New Safety Warnings Added to Prescription Opioid Medications
ISSUE: FDA is warning about several safety issues with the entire class of opioid pain medicines. See the FDA Drug Safety Communication for a complete listing. These safety risks are potentially h...
FDA Medwatch Alert: Compounded Drugs Stored in Becton-Dickinson (BD) 3 ml and 5 ml Syringes: FDA Warning - Do Not Use
ISSUE: FDA is alerting health care professionals not to administer to patients compounded or repackaged drugs that have been stored in 3 milliliter (ml) and 5ml syringes manufactured by...
FDA Medwatch Alert: Fentanyl Transdermal System CII Patches
[UPDATED 03/03/2008] Actavis Inc. has voluntarily recalled of all lots of Fentanyl Transdermal System CII patches sold in the United States.[Posted 02/19/2008] Actavis Inc. announced a nationwide...
FDA Medwatch Alert: Fentanyl transdermal system CII Patches
[Posted 02/19/2008] Actavis Inc. announced a nationwide recall of certain lots of Fentanyl transdermal system CII Patches sold in the United States and labelled with an Abrika or Actavis label. The...
FDA Medwatch Alert: Duragesic 25 mcg/hr (fentanyl transdermal system) CII Pain Patches
[Posted 02/15/2008] PriCara and Sandoz Inc. announced a nationwide recall of all lots of 25 mcg/hr Duragesic Patches sold in the United States. The product is being recalled because the patches may...
FDA Medwatch Alert: Fentanyl Transdermal System (marketed as Duragesic and generics)
[Posted 12/21/2007] FDA issued an update that highlights important information on appropriate prescribing, dose selection, and the safe use of the fentanyl transdermal system (patch). FDA previously...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Breakthrough Pain, Chronic Pain, Pain